MFDS — authorised 22 June 1982
- Marketing authorisation holder: BAXTER HLTHCARE
- Status: likely_approved
🇰🇷 Renacidin in South Korea
MFDS authorised Renacidin on 22 June 1982
Marketing authorisation
Renacidin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in South Korea
Frequently asked questions
Is Renacidin approved in South Korea?
Yes. MFDS authorised it on 22 June 1982.
Who is the marketing authorisation holder for Renacidin in South Korea?
BAXTER HLTHCARE holds the South Korean marketing authorisation.